Status:
COMPLETED
Magnesium Sulphate Injection in Treatment of Myofascial Trigger Points
Lead Sponsor:
Fayoum University
Conditions:
Trigger Point Pain, Myofascial
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
This is a prospective, single- center, randomized (1:1) clinical trial comparing the effectiveness of magnesium sulphate injections in treatment of myofascial trigger points in the masseter muscle ver...
Detailed Description
The proposal presents the magnesium sulphate (MgSO4) as a possible injection treatment for TrPs. The MgSO4 prevents the release of pre-synaptic acetylcholine from neuromuscular and sympathetic junctio...
Eligibility Criteria
Inclusion
- Definite diagnosis of myofascial pain with a referral, based on the DC/TMD criteria
- the presence of one or more trigger points in the unilateral or bilateral masseter muscle
- no history of any invasive procedures in the related masseter muscle.
Exclusion
- Factors that can cause pain in the orofacial region other than MTPs (decayed tooth, TMJ internal disorder).
- Any systemic disease that possibly affects the masticatory system such as rheumatoid arthritis and epilepsy
- pregnancy and lactation.
Key Trial Info
Start Date :
February 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04742140
Start Date
February 20 2021
End Date
September 1 2021
Last Update
December 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry
Al Fayyum, Egypt, 63514